PCOS Root Causes: Functional Testing & Hormone Balance
Quick Answer
Polycystic Ovary Syndrome (PCOS) is a metabolic-endocrine condition driven by insulin resistance, chronic low-grade inflammation, and disrupted androgen regulation. A functional medicine approach uses targeted testing, including the DUTCH Complete hormone panel, to identify individual drivers such as hyperinsulinaemia, elevated cortisol, and impaired oestrogen metabolism, then applies personalised nutrition and lifestyle strategies to restore hormonal balance.
This may involve targeted lifestyle interventions alongside functional testing to assess insulin signalling, androgen activity, cortisol patterns, and hormone metabolism (4–6).
At a Glance
- PCOS affects up to 13% of women of reproductive age and is recognised as a multisystem metabolic-endocrine condition, not solely a reproductive disorder (1,2).
- Insulin resistance is present in approximately 70% of women with PCOS and may drive compensatory hyperinsulinaemia and excess ovarian androgen production (3,7).
- Chronic low-grade inflammation, often linked to gut microbiome disruption and adipokine imbalance, can worsen both insulin resistance and hormonal dysregulation (8,9).
- The DUTCH Complete test measures sex hormone metabolites, diurnal cortisol patterns, and androgen clearance pathways to inform personalised management strategies (10).
- Myo-inositol supplementation may improve insulin sensitivity and ovulatory function in women with PCOS, according to systematic reviews of randomised controlled trials (14,15).
PCOS: More Than Just a Reproductive Condition
PCOS is one of the most common endocrine disorders in women of reproductive age, with prevalence estimates ranging from 8% to 13% depending on the diagnostic criteria applied (1). The condition is typically diagnosed based on a combination of ovulatory dysfunction, hyperandrogenism, and polycystic ovarian morphology using the Rotterdam criteria. Increasingly, research by Andrea Dunaif and others suggests that PCOS is best understood as a multisystem metabolic-endocrine condition rather than a purely gynaecological disorder (2,3).
Many women with PCOS experience symptoms beyond the reproductive system, including persistent fatigue, difficulty managing weight, mood disturbances, and sugar cravings. These features often reflect underlying disturbances in insulin signalling, inflammatory pathways, and hypothalamic-pituitary-adrenal (HPA) axis dysregulation, which are commonly explored in patients presenting with chronic fatigue.
Key Mechanisms Involved in PCOS
| Mechanism | Description | Key References |
|---|---|---|
| Insulin resistance | Reduced cellular responsiveness to insulin can lead to compensatory hyperinsulinaemia, which may stimulate excess ovarian androgen production via cytochrome P450c17 enzyme activity and disrupt ovulation | (3,7) |
| Chronic low-grade inflammation | Elevated C-reactive protein (CRP), interleukin-6 (IL-6), and tumour necrosis factor-alpha (TNF-alpha) appear more frequently in PCOS and may worsen insulin resistance and hormonal dysregulation. This inflammatory burden is often influenced by gut health and the gut microbiome | (8,9) |
| Hormonal imbalance | Elevated androgens (testosterone, DHEA-S, androstenedione) and altered luteinising hormone (LH) to follicle-stimulating hormone (FSH) ratios can interfere with normal follicular development and ovulation | (2) |
How Functional Testing Can Support a Root-Cause Approach
Functional medicine testing provides additional physiological context alongside standard medical assessment, including fasting insulin, sex hormone-binding globulin (SHBG), and lipid panels commonly ordered by endocrinologists and gynaecologists. These tools are not diagnostic for PCOS, but may offer useful insight into patterns that influence symptom severity, metabolic health, and hormonal regulation.
DUTCH Hormone Testing
The Dried Urine Test for Comprehensive Hormones (DUTCH), developed by Precision Analytical, evaluates sex hormones, their metabolites, and diurnal cortisol patterns via dried urine samples collected over a 24-hour period. In women with PCOS, DUTCH testing may help explore:
| Parameter Assessed | Clinical Relevance to PCOS |
|---|---|
| Cortisol rhythm (free cortisol and cortisone) | May reveal HPA axis dysregulation contributing to adrenal androgen excess |
| Oestrogen metabolism (2-OH, 4-OH, 16-OH pathways) | Can indicate methylation and detoxification capacity via COMT enzyme activity |
| Relative progesterone output | May reflect anovulatory cycles and luteal phase insufficiency |
| Androgen production and clearance (5-alpha reductase activity) | Helps distinguish ovarian from adrenal sources of excess androgens |
When clinically appropriate, comprehensive hormone testing such as the DUTCH Complete test can be used to support a personalised care plan. All results must be interpreted within the broader clinical picture and are used to inform care strategies rather than replace conventional diagnostic criteria (10–12).
A Multi-Layered Strategy for Managing PCOS
Research published in the Endocrine Society’s guidelines and the 2023 International Evidence-Based PCOS Guideline led by Helena Teede confirms that effective PCOS management typically requires a personalised and multi-factorial strategy addressing metabolic, inflammatory, and lifestyle contributors concurrently (2,6).
Nutrition Support
| Dietary Strategy | Mechanism of Action |
|---|---|
| Low-glycaemic dietary patterns | Supporting stable blood glucose levels may help reduce insulin demand and downstream androgen excess (7) |
| Anti-inflammatory foods | Diets rich in cruciferous vegetables, omega-3 fatty acids (EPA and DHA), and soluble fibre may help modulate NF-kB inflammatory signalling (8,13) |
| Reducing ultra-processed foods | Excess refined carbohydrates, seed oils, and added sugars may exacerbate insulin resistance and metabolic stress |
Nutrient Support (When Clinically Indicated)
| Nutrient | Evidence Summary |
|---|---|
| Myo-inositol | May support insulin sensitivity and ovulatory function in some women with PCOS, as demonstrated in systematic reviews by Unfer et al. (14,15) |
| Omega-3 fatty acids (EPA/DHA) | Associated with improvements in inflammatory markers (CRP, IL-6) and lipid profiles, as reviewed by Simopoulos (13,16) |
| Magnesium | Plays a role in glucose metabolism via GLUT4 transporter activity, nervous system regulation, and stress resilience (17) |
| Vitamin D | Low 25-hydroxyvitamin D status is commonly observed in PCOS and may be associated with metabolic and reproductive features, as reported by Irani et al. (18,19) |
Lifestyle Interventions
- Regular physical activity: Both resistance training and aerobic exercise may improve insulin sensitivity and cardiometabolic health markers, including HOMA-IR and waist circumference (20).
- Stress regulation: Mind-body practices such as yoga, meditation, and diaphragmatic breathing can support cortisol balance and neuroendocrine function, which may overlap with thyroid and stress-related patterns discussed in thyroid health.
- Sleep quality: Consistent, restorative sleep (7–9 hours) is essential for melatonin production, hormonal regulation, and glucose control.
When to Consider Functional Assessment
Functional assessment may be appropriate for women with PCOS who continue to experience symptoms despite standard interventions, or where metabolic features such as insulin resistance, fatigue, or HPA axis dysfunction are prominent. Testing should always be guided and interpreted by a qualified practitioner such as a clinical nutritionist or integrative medicine practitioner with experience in hormonal health.
Next Steps
- Assess your metabolic foundations: Review your dietary patterns, blood glucose stability, and insulin sensitivity markers (fasting insulin, HOMA-IR, HbA1c) with your practitioner to identify key metabolic drivers.
- Consider comprehensive hormone testing: A DUTCH Complete or similar panel can provide insight into cortisol rhythms, androgen metabolism, and oestrogen clearance pathways relevant to PCOS.
- Build a personalised strategy: Work with a qualified functional medicine practitioner to integrate nutrition, lifestyle, and targeted support based on your individual test results and symptom patterns.
Frequently Asked Questions
Key Insights
- PCOS is a multisystem metabolic-endocrine condition, not solely a reproductive disorder
- Insulin resistance and chronic low-grade inflammation play central roles in driving PCOS symptoms
- Functional testing such as DUTCH hormone panels can support personalised care when used appropriately
- Long-term management focuses on metabolic and hormonal resilience through nutrition, lifestyle, and targeted support
Citable Takeaways
- PCOS affects up to 13% of women of reproductive age and is classified as a multisystem metabolic-endocrine condition according to the International Evidence-Based PCOS Guideline led by Teede et al. (2).
- Insulin resistance is present in approximately 70% of women with PCOS and may drive compensatory hyperinsulinaemia that stimulates excess ovarian androgen production, as described by Dunaif (3) and Legro et al. (7).
- Chronic low-grade inflammation, characterised by elevated CRP, IL-6, and TNF-alpha, appears more frequently in PCOS and may worsen both insulin resistance and hormonal dysregulation, according to Repaci et al. (9).
- Myo-inositol supplementation may improve insulin sensitivity and ovulatory function in women with PCOS, as demonstrated in a systematic review of randomised controlled trials by Unfer et al. (14).
- The DUTCH Complete test evaluates sex hormone metabolites, diurnal cortisol patterns, and androgen clearance pathways, providing physiological context for personalised PCOS management strategies, as validated by Newman et al. (10).
- Both resistance training and aerobic exercise may improve insulin sensitivity and cardiometabolic health markers in women with PCOS, as reported in a systematic review by Harrison et al. (20).
Take a Root-Cause Approach to PCOS
If you are seeking a personalised, evidence-informed approach to PCOS care that goes beyond symptom suppression, functional medicine assessment can help identify the metabolic and hormonal drivers unique to you. At Elemental Health and Nutrition, we integrate comprehensive testing with targeted nutrition and lifestyle strategies to support long-term hormonal balance.
References
- Azziz R et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016 Apr 28;2:16057. https://doi.org/10.1038/nrdp.2016.57
- Teede HJ et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018 Sep 1;33(9):1602-1618. https://doi.org/10.1093/humrep/dey256
- Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997 Dec;18(6):774-800. https://doi.org/10.1210/edrv.18.6.0318
- Diamanti-Kandarakis E et al. Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab. 2007 Mar;18(2):72-8. https://doi.org/10.1016/j.tem.2006.12.002
- Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016 Oct;37(5):467-520. https://doi.org/10.1210/er.2015-1104
- Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018 May;14(5):270-284. https://doi.org/10.1038/nrendo.2018.24
- Legro RS et al. Insulin resistance in polycystic ovary syndrome: concepts, measurement, genetics and treatment. Endocrinol Metab Clin North Am. 2011 Mar;40(1):1-17. https://doi.org/10.1016/j.ecl.2010.10.003
- González F. Nutrient-induced inflammation in polycystic ovary syndrome: a potential role for the gut microbiome. Reprod Sci. 2012 Nov;19(11):1155-63. https://doi.org/10.1177/1933719112459229
- Repaci A et al. Chronic inflammation and PCOS: the role of adipokines. Int J Mol Sci. 2011;12(12):9284-93. https://doi.org/10.3390/ijms12129284
- Newman M et al. Dried urine hormone testing methodology: validation and clinical utility. Steroids. 2019 Nov;151:108457. https://doi.org/10.1016/j.steroids.2019.108457
- Stanczyk FZ. Measurement of androgens in women. Semin Reprod Med. 2006 Mar;24(2):78-85. https://doi.org/10.1055/s-2006-931797
- Auchus RJ. Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic. J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):71-78. https://doi.org/10.1016/j.jsbmb.2016.02.002
- Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002 Dec;21(6):495-505. https://doi.org/10.1080/07315724.2002.10719248
- Unfer V et al. Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecol Endocrinol. 2017;33(11):875-883. https://doi.org/10.1080/09513590.2017.1336174
- Pizzo A et al. Myo-inositol in the treatment of polycystic ovary syndrome. Eur Rev Med Pharmacol Sci. 2014;18(13):1896-903. https://pubmed.ncbi.nlm.nih.gov/25010644/
- Mohammadi E et al. Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome. J Ovarian Res. 2012 Jul 16;5(1):15. https://doi.org/10.1186/1757-2215-5-15
- Barbagallo M et al. Magnesium and insulin sensitivity in overweight/obese women with PCOS. Curr Pharm Des. 2014;20(31):5031-7. https://doi.org/10.2174/1381612820666140630100125
- Wehr E et al. Association of vitamin D status with serum androgen levels in men. Eur J Endocrinol. 2009 Dec;161(6):947-52. https://doi.org/10.1530/EJE-09-0577
- Irani M et al. Vitamin D deficiency is prevalent among infertile women and is associated with metabolic syndrome markers. Fertil Steril. 2014 Jun;101(6):1674-80. https://doi.org/10.1016/j.fertnstert.2014.02.030
- Harrison CL et al. Exercise therapy in polycystic ovary syndrome: a systematic review. Hum Reprod Update. 2011 Mar-Apr;17(2):171-83. https://doi.org/10.1093/humupd/dmq045
- Chrousos GP. Stress and endocrine regulation. Endocrinol Metab Clin North Am. 2000 Jun;29(2):xv-xvi. https://doi.org/10.1016/s0889-8529(05)70132-9
